Iverson Genetic Diagnostics Inc.

Iverson is partnering with the Swank MS Foundation in the validation and development of quantitative, gene-based diagnostics for clinical use.
read more...

Learn about Dr. Swank's extraordinary work at the Swank MS Foundation. And how to make the most informed choices about treatment of MS. Watch the You Tube video here...

Press Release: Iverson Genetics CEO Dean I. Spoles to speak at Burrill and Company's Pacific Northwest Life Sciences Meeting May 6th, 2008 in Portland, Oregon.
read more...

DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results

Iverson joins the Puget Sound Healthcare Alliance

Iverson attends the 19th annual Washington Physician Assistant Winter Conference in Seattle, WA January 26th-28th

Thrombosis, Warfarin Dosing, Tamoxifen Response, Factor II, Factor V and MTHFR Assays Validated

Iverson Announces the Successful Completion of Series A Financing

Science Magazine announces "Human Genetic Variation" as the Breakthrough of the Year

Welcome to the Age of Genomics. Nov 07 issue of Wired Magazine devoted to the advent of retail genomics

Iverson to attend the East Coast Reception hosted by Personalized Medicine Coalition - Jan 17^th, 2008.

Iverson joins WBBA

Iverson registers for the American Association of Clinical Chemistry

Iverson becomes a member of the Genetic Alliance

Iverson attends �From Prediction to Prevention� The Annual Burrill Personalized Medicine Meeting presented by Burrill Life Sciences Media Group-November -12-13, 2007

Iverson attends The American Society of Human Genetics 57^th Annual Meeting-October 23-27, 2007

Iverson to attend �Eyes on the Prize� Summit hosted by Genetic Alliance � September 20 � 21st, 2007

Iverson obtains CLIA Certification

Satterlee and Dubay appointed to Iverson's Board of Directors